HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yang Xia Selected Research

Bisphosphoglycerate Mutase (Diphosphoglycerate Mutase)

1/2022Erythrocyte transglutaminase-2 combats hypoxia and chronic kidney disease by promoting oxygen delivery and carnitine homeostasis.
1/2020Erythrocyte Metabolic Reprogramming by Sphingosine 1-Phosphate in Chronic Kidney Disease and Therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yang Xia Research Topics

Disease

56Neoplasms (Cancer)
12/2022 - 08/2006
34Inflammation (Inflammations)
05/2022 - 09/2007
32Pre-Eclampsia (Preeclampsia)
01/2020 - 02/2003
31Hypoxia (Hypoxemia)
01/2022 - 01/2012
28Hypertension (High Blood Pressure)
01/2022 - 08/2008
19Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2013
14Proteinuria
01/2020 - 08/2008
13Fibrosis (Cirrhosis)
01/2020 - 08/2005
12Sickle Cell Anemia (Hemoglobin S Disease)
01/2022 - 01/2011
9Neoplasm Metastasis (Metastasis)
02/2022 - 10/2014
9Infections
01/2022 - 05/2011
9Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 11/2008
9Lung Neoplasms (Lung Cancer)
01/2021 - 01/2013
8Disease Progression
01/2019 - 06/2014
8Priapism
06/2014 - 04/2008
7Pulmonary Hypertension
01/2020 - 06/2012
6Adenocarcinoma of Lung
03/2022 - 01/2016
6Non-alcoholic Fatty Liver Disease
11/2019 - 11/2016
6Type 2 Diabetes Mellitus (MODY)
03/2019 - 08/2015
5Carcinogenesis
12/2022 - 01/2012
5Brain Injuries (Brain Injury)
04/2019 - 02/2013
5Hemolysis
01/2018 - 08/2008
4Esophageal Squamous Cell Carcinoma
01/2022 - 01/2014
4Temporal Lobe Epilepsy
04/2021 - 07/2013
4Osteoarthritis
01/2021 - 10/2015
4AIDS-Related Complex (ARC)
03/2020 - 09/2013
4Pain (Aches)
01/2020 - 01/2016
4Breast Neoplasms (Breast Cancer)
11/2019 - 01/2017
4Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2019 - 08/2005
4Lung Diseases (Lung Disease)
01/2019 - 08/2005
4Wounds and Injuries (Trauma)
10/2017 - 05/2011
4Pneumonia (Pneumonitis)
08/2013 - 08/2005
3Body Weight (Weight, Body)
08/2022 - 04/2014
3Cognitive Dysfunction
01/2022 - 02/2016
3Chronic Renal Insufficiency
01/2022 - 07/2015
3Neuroblastoma
10/2021 - 09/2013
3Status Epilepticus (Complex Partial Status Epilepticus)
04/2021 - 02/2016
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 01/2018
3Adenocarcinoma
01/2021 - 01/2014
3Demyelinating Diseases (Demyelinating Disease)
12/2020 - 01/2014
3Acute Kidney Injury (Acute Renal Failure)
05/2020 - 01/2012
3Prostatic Neoplasms (Prostate Cancer)
01/2020 - 12/2014

Drug/Important Bio-Agent (IBA)

39Adenosine (Adenocard)FDA LinkGeneric
01/2022 - 08/2005
24AutoantibodiesIBA
08/2017 - 02/2003
17Biomarkers (Surrogate Marker)IBA
12/2022 - 08/2010
17MicroRNAs (MicroRNA)IBA
01/2022 - 01/2012
17Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2008
16CytokinesIBA
01/2021 - 05/2010
16Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2016 - 02/2003
13Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2018 - 09/2007
11Interleukin-6 (Interleukin 6)IBA
01/2020 - 05/2011
11EnzymesIBA
01/2020 - 09/2007
9Biological ProductsIBA
12/2022 - 10/2009
9Angiotensin IIIBA
01/2020 - 09/2004
9Tyrosine (L-Tyrosine)FDA Link
01/2017 - 01/2007
8Long Noncoding RNAIBA
01/2021 - 01/2016
8Pharmaceutical PreparationsIBA
07/2019 - 09/2010
8Immunoglobulin G (IgG)IBA
08/2018 - 02/2003
8Adenosine DeaminaseIBA
01/2017 - 08/2005
7Messenger RNA (mRNA)IBA
01/2022 - 03/2010
7Oxygen (Dioxygen)IBA
01/2022 - 05/2013
7Adenosine A2B ReceptorIBA
01/2021 - 12/2013
6Hemoglobins (Hemoglobin)IBA
01/2022 - 05/2013
6Peptides (Polypeptides)IBA
10/2021 - 05/2014
6Immune Checkpoint InhibitorsIBA
09/2021 - 01/2020
6Pilocarpine (Ocusert)FDA LinkGeneric
04/2021 - 11/2009
6C-Reactive ProteinIBA
01/2020 - 01/2013
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2019 - 01/2010
6osthol (osthole)IBA
04/2019 - 01/2014
6Interleukin-10 (Interleukin 10)IBA
09/2016 - 02/2011
5DNA (Deoxyribonucleic Acid)IBA
06/2021 - 01/2013
5ErbB Receptors (EGF Receptor)IBA
01/2021 - 01/2014
5sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2020 - 06/2014
5Glucose (Dextrose)FDA LinkGeneric
01/2020 - 08/2016
5CreatinineIBA
01/2019 - 05/2010
5Immunoglobulin M (IgM)IBA
08/2018 - 01/2008
5AntibodiesIBA
01/2016 - 09/2004
4Glutathione (Reduced Glutathione)IBA
03/2022 - 10/2016
4ORALIT (ORS)IBA
01/2022 - 01/2020
4Therapeutic UsesIBA
11/2021 - 09/2010
4CateninsIBA
10/2020 - 01/2012
42,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)IBA
01/2020 - 10/2016
4Equilibrative Nucleoside Transporter 1IBA
01/2020 - 01/2012
4Hyaluronic Acid (Hyaluronan)IBA
01/2019 - 12/2013
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2018 - 01/2007
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2018 - 01/2007
4Alanine Transaminase (SGPT)IBA
09/2018 - 11/2016
4Immunoglobulins (Immunoglobulin)IBA
08/2018 - 05/2016
4Immunoglobulin E (IgE)IBA
08/2018 - 06/2012
4CalcineurinIBA
04/2008 - 11/2005
3RNA (Ribonucleic Acid)IBA
03/2022 - 01/2020
3Fluconazole (Zonal)FDA LinkGeneric
01/2021 - 10/2015
3Tyrosine Kinase InhibitorsIBA
01/2021 - 01/2019
3CarbohydratesIBA
01/2021 - 11/2008
3Serotonin (5 Hydroxytryptamine)IBA
01/2020 - 10/2013
3Indicators and Reagents (Reagents)IBA
11/2019 - 11/2015

Therapy/Procedure

41Therapeutics
01/2022 - 01/2007
5Immunotherapy
01/2022 - 01/2020
5Enzyme Therapy
12/2020 - 08/2005
4Drug Therapy (Chemotherapy)
06/2021 - 01/2007